Burrill & Company

edit

Burrill & Company invests in life science companies whose technologies and products are applicable across a wide range of life science sub-sectors: human healthcare therapeutics and diagnostics/devices; health/wellness; agricultural biotechnology; biofuels, and industrial biotechnology (biomaterials/bioprocesses).

Milestones

edit

• 
  Burrill & Company invested in PrimeraDx. (10/30/09)
  Posted 10/30/09 at 5:51pm
• 
  Burrill & Company invested in XDx. (10/7/09)
  Posted 10/7/09 at 3:26pm
• 
  Burrill & Company invested in XDx. (8/5/09)
  Posted 9/24/09 at 1:47pm
• 
  Burrill & Company invested in HCL CleanTech. (6/1/09)
  Posted 6/17/09 at 12:40pm
• 
  Burrill & Company invested in Aerovance. (4/7/09)
  Posted 4/10/09 at 8:36am
• 
  Burrill & Company invested in Catalyst Biosciences. (12/3/08)
  Posted 6/23/09 at 10:50am
• 
  Burrill & Company invested in Gevo. (5/13/08)
  Posted 6/28/09 at 11:13pm
• 
  Burrill & Company invested in Osprey Pharmaceuticals USA. (5/08)
  Posted 6/18/09 at 4:33pm
• 
  Burrill & Company invested in Aerovance. (3/28/07)
  Posted 6/19/09 at 10:47am

Investments

Videos

Sources

1. PrimeraDx, Inc.: Series C $20M (onbiovc.com) [edit]
2. XDx, Inc.: Series G $14.4M (onbiovc.com) [edit]
3. XDx raises $14.4M new funding (sanjose.bizjournals.com) [edit]
4. Khosla Invests Still More In Biofuels: HCL CleanTech (earth2tech.com) [edit]
5. Aerovance inhales $38M for asthma drugs (venturebeat.com) [edit]
6. Catalyst Biosciences Raises $40 Million in Series C Financing (fiercebiotech.com) [edit]
7. Gevo raises another $17M for synthetic biofuels (deals.venturebeat.com) [edit]
8. Osprey Pharmaceuticals (ospreypharma.com) [edit]
9. Aerovance, asthma treatment company, finishes raising $60M (deals.venturebeat.com) [edit]